Alternaturals plans for new manufacturing facility to meet expected revenue growth

After positive negotiations with major international affiliate marketers, Alternaturals is confident that the company will see significant growth in 2015 to warrant its own facility. As a result, the company has started planning for the the development of a large-scale manufacturing facility to service the anticipated massive surge in demand.

"We have already undertaken more traditional forms of online marketing and have achieved an increase in revenue with an average advertising cost of 23% for Sombium and Focamine. We are pleased with the growth and are enthusiastic about implementing more aggressive plans for these products, as well as for the release of Cellurite and Priapin," said Matthew Briggs, CEO.

An analysis of the affiliate program has allowed Alternaturals to forecast an increase in annual revenue of several million dollars, yielding a sizable gross profit. Company management is expected to wrap up negotiations in the next thirty days, and to be functioning at full capacity ninety days after that.

Mr. Briggs added, "Not only are we preparing for the massive influx in revenue from the affiliate program, but working with large retailers is a big part of the company’s future plans as well. These two revenue streams require large-scale facilities to manufacture and ship product. We are enthusiastically looking forward to servicing this level of business, but we must be prepared to deliver the product."

"I am extremely excited to be entering this phase in the company’s development. My previous experience with affiliate marketing has been positive and we are entering into relationships with sources who are known as proven performers. The ability to drive significant revenue through online marketing powerhouses is a big part of why I came to Alternaturals." Said Mark Tiarra, CTO.